LFMD Q4 2025 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q4 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$47M-27.1% YoY

Gross Profit

$41M87.1% margin

Operating Income

-$7M-15.7% margin

Net Income

$19M40.9% margin

EPS (Diluted)

$0.41

QoQ Revenue Growth

-22.1%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$70M

Total Liabilities

$47M

Stockholders' Equity

$23M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$64M	-27.1%
Gross Profit	$41M	$55M	-25.5%
Operating Income	-$7M	$1M	-820.5%
Net Income	$19M	-$106,272	+18154.7%